Clorox (CLX) director adds deferred stock units via 2025 awards

Rhea-AI Filing Summary

The Clorox Company director reported routine equity compensation activity in the form of deferred stock units. The filing shows several acquisitions of deferred stock units tied to Clorox common stock during 2025, including transactions dated 02/14/2025, 05/09/2025, 08/29/2025, 11/06/2025, and 12/31/2025. These awards were recorded at an exercise price of $0.0000 per unit.

The director’s beneficial holdings in these derivative securities increased to 15,677.4328 deferred stock units held directly. The explanation notes that some units were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan, while an additional annual award was granted under the 2005 Stock Incentive Plan. Each deferred stock unit represents a 1-for-1 right to receive Clorox stock, to be settled in shares upon the director’s retirement or other termination of service from the board.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lee Esther

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/14/2025		A(2)	V	111.336		(3)	(3)	Common Stock	111.336	$0.0000	13,610.3691	D
Deferred Stock Units	(1)	05/09/2025		A(2)	V	123.2165		(3)	(3)	Common Stock	123.2165	$0.0000	13,733.5856	D
Deferred Stock Units	(1)	08/29/2025		A(2)	V	144.0748		(3)	(3)	Common Stock	144.0748	$0.0000	13,877.6604	D
Deferred Stock Units	(1)	11/06/2025		A(2)	V	161.9147		(3)	(3)	Common Stock	161.9147	$0.0000	14,039.5751	D
Deferred Stock Units	(1)	12/31/2025		A(4)		1,637.8577		(3)	(3)	Common Stock	1,637.8577	$0.0000	15,677.4328	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.

	By Angela Hilt, Attorney-in-Fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Clorox (CLX) report in this Form 4?

The filing reports a Clorox director acquiring deferred stock units linked to Clorox common stock through multiple 2025 transactions, including dividend reinvestment and an annual equity award.

How many deferred stock units does the Clorox (CLX) director now beneficially own?

After the reported transactions, the director beneficially owns 15,677.4328 deferred stock units directly.

On what dates in 2025 were the Clorox (CLX) deferred stock unit transactions reported?

The transactions in deferred stock units are dated 02/14/2025, 05/09/2025, 08/29/2025, 11/06/2025, and 12/31/2025.

What plans govern the Clorox (CLX) director’s deferred stock units?

The filing states that units were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan and via an annual award under the 2005 Stock Incentive Plan.

How will the Clorox (CLX) deferred stock units be settled for the director?

According to the disclosure, the deferred stock units will be settled 100% in Clorox stock when the director retires or otherwise terminates service as a board member.

What does 1-for-1 mean for Clorox (CLX) deferred stock units?

The explanation notes that each deferred stock unit represents a 1-for-1 right to receive one share of Clorox common stock upon settlement.